Cost-effectiveness analysis of intravenous ferumoxytol for the treatment of iron deficiency anemia in adult patients with non-dialysis-dependent chronic kidney disease in the USA

por Dahl, Naomi V, Kaper, Robert F, Strauss, William E, Corvino, Frank A, Zivkovic, Marko
Publicado en Clinicoecon Outcomes Res (2017)

Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind stud...

por Adkinson, N Franklin, Strauss, William E, Bernard, Kristine, Kaper, Robert F, Macdougall, Iain C, Krop, Julie S
Publicado en J Blood Med (2017)

Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial

por Adkinson, N. Franklin, Strauss, William E., Macdougall, Iain C., Bernard, Kristine E., Auerbach, Michael, Kaper, Robert F., Chertow, Glenn M., Krop, Julie S.
Publicado en Am J Hematol (2018)